Interstitial lung disease: Difference between revisions
From IDWiki
(Imported from text file) |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 2: | Line 2: | ||
* Primary |
* Primary |
||
− | ** IPF |
+ | ** [[IPF]] |
− | ** COP |
+ | ** [[COP]] |
− | ** NSIP |
+ | ** [[NSIP]] |
* Secondary |
* Secondary |
||
** Inflammatory or connective tissue diseases |
** Inflammatory or connective tissue diseases |
||
− | *** Rheumatoid arthritis |
+ | *** [[Rheumatoid arthritis]] |
− | *** Systemic lupus erythematosus |
+ | *** [[Systemic lupus erythematosus]] |
− | *** Dermatomyositis |
+ | *** [[Dermatomyositis]] |
− | *** Systemic sclerosis |
+ | *** [[Systemic sclerosis]] |
− | *** Sarcoidosis |
+ | *** [[Sarcoidosis]] |
** Exposures |
** Exposures |
||
− | *** Hypersensitivity pneumonitis |
+ | *** [[Hypersensitivity pneumonitis]] |
+ | *** Drugs: [[nitrofurantoin]], chemotherapy ([[cyclophosphamide]], [[bleomycin]]), [[methotrexate]], [[amiodarone]] |
||
− | *** Inorganic |
||
+ | *** Inorganic exposures: [[silicosis]] and [[asbestosis]] |
||
− | **** Silica |
||
⚫ | |||
− | **** Asbestos |
||
+ | **** [[Hypersensitivity pneumonitis]], including bird fancier's lung, cheese-washer's lung, farmer's lung |
||
− | *** Drugs |
||
− | **** [[ |
+ | **** Hot tub lung ([[Mycobacterium avium]]) |
⚫ | |||
− | **** Chemotherapy |
||
− | ***** Cyclophosphamide |
||
− | ***** Others |
||
− | **** Methotrexate |
||
− | *** Organic |
||
⚫ | |||
⚫ | |||
* Mimickers |
* Mimickers |
||
− | ** Congestive heart failure |
+ | ** [[Congestive heart failure]] |
** Interstitial infections |
** Interstitial infections |
||
*** [[Pneumocystis jirovecii pneumonia]] |
*** [[Pneumocystis jirovecii pneumonia]] |
||
Line 33: | Line 27: | ||
*** [[Legionella]] |
*** [[Legionella]] |
||
*** Viral pneumonia |
*** Viral pneumonia |
||
− | ** Lymphangitic carcinomatosis |
+ | ** [[Lymphangitic carcinomatosis]] |
+ | |||
+ | === By Location Predominance === |
||
+ | |||
+ | ==== Upper Lobe Predominance (HASTEN) ==== |
||
+ | |||
+ | * [[Hypersensitivity pneumonitis]] |
||
+ | * [[Ankylosing spondylitis]] |
||
+ | * [[Sarcoidosis]] and [[silicosis]] |
||
+ | * [[Tuberculosis]], viral pneumonia, [[Mycoplasma]] |
||
+ | * Eosinophilic granulomas (aka pulmonary [[Langerhan cell histiocytosis]], present with spontaneous pneumothorax) |
||
+ | * [[Neurofibromatosis]] |
||
+ | |||
+ | ==== Lower Lobe Predominance (BAD RASH) ==== |
||
+ | |||
+ | * [[Bleomycin]] |
||
+ | * [[Amiodarone]] |
||
+ | * Drugs: [[nitrofurantoin]], [[cyclophosphamide]], [[methotrexate]] |
||
+ | * [[Rheumatoid lung]] |
||
+ | * [[Asbestosis]] |
||
+ | * [[Scleroderma]] |
||
+ | * [[Hamman-Rich syndrome]] (aka [[acute interstitial pneumonia]] = rare, fulminant form of IPF) |
||
[[Category:Respirology]] |
[[Category:Respirology]] |
Latest revision as of 11:56, 18 February 2023
Differential Diagnosis
- Primary
- Secondary
- Inflammatory or connective tissue diseases
- Exposures
- Hypersensitivity pneumonitis
- Drugs: nitrofurantoin, chemotherapy (cyclophosphamide, bleomycin), methotrexate, amiodarone
- Inorganic exposures: silicosis and asbestosis
- Occupational and hobby exposures
- Hypersensitivity pneumonitis, including bird fancier's lung, cheese-washer's lung, farmer's lung
- Hot tub lung (Mycobacterium avium)
- Radiation pneumonitis
- Mimickers
- Congestive heart failure
- Interstitial infections
- Pneumocystis jirovecii pneumonia
- Mycoplasma
- Legionella
- Viral pneumonia
- Lymphangitic carcinomatosis
By Location Predominance
Upper Lobe Predominance (HASTEN)
- Hypersensitivity pneumonitis
- Ankylosing spondylitis
- Sarcoidosis and silicosis
- Tuberculosis, viral pneumonia, Mycoplasma
- Eosinophilic granulomas (aka pulmonary Langerhan cell histiocytosis, present with spontaneous pneumothorax)
- Neurofibromatosis
Lower Lobe Predominance (BAD RASH)
- Bleomycin
- Amiodarone
- Drugs: nitrofurantoin, cyclophosphamide, methotrexate
- Rheumatoid lung
- Asbestosis
- Scleroderma
- Hamman-Rich syndrome (aka acute interstitial pneumonia = rare, fulminant form of IPF)